Read this article:
Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call
Author Archives: Fredricko
Emerald Bioscience Launches Rebrand Including Name Change to Skye Bioscience
Here is the original post:
Emerald Bioscience Launches Rebrand Including Name Change to Skye Bioscience
NexImmune Appoints Healthcare Innovator Grant Verstandig as New Board Member
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
Novan Provides Enrollment Update and Announces New Corporate Headquarters
Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant
Bespoke Extracts Increases Conversion Price of Outstanding Discount Convertible Debentures
Read the original here:
Bespoke Extracts Increases Conversion Price of Outstanding Discount Convertible Debentures
Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes
Theratechnologies Announces Closing of US$46 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
Tauriga Sciences Inc. to Construct Product Showroom Within its New Corporate Headquarters
Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference
VIRBAC:2020 annual revenue shows strong growth of +5.7% at constant exchange rates and scope (+3.2% at constant rates)
Agenus to Participate in B. Riley Securities’ Oncology Investor Conference
See the rest here:
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
Here is the original post:
Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.
Histogen Reports FDA Clinical Hold for Planned Phase 1/2 Trial of HST-003 for Knee Cartilage Regeneration
Shockwave Medical to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
Eledon Pharmaceuticals to Participate in the Virtual Noble Capital Markets’ Seventeenth Annual Investor / Equity Conference
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference
Go here to see the original:
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference